Covista Inc.

Listed Company

CVSACIK 0000730464NYSELarge AcceleratedServices-Educational ServicesDelawareFY ends Jun 30

Period

FY 2025

Revenue

$1.79B

Net Income

$237.06M

Total Assets

$2.75B

Equity

$1.43B

Shares Out

34.03M

Op. Cash Flow

$337.90M

CVSA$117.87+18.25% · past 5 monthsDBEQ Basic

Daily closing prices

Business

Adtalem Global Education Inc. operates five accredited postsecondary healthcare education institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine, collectively serving approximately 90,000 students. The company offers degree and certificate programs in nursing, health professions, medicine, veterinary medicine, public health, social work, education, business, and other disciplines through campus and online delivery. Adtalem operates three reportable segments—Chamberlain, Walden, and Medical and Veterinary—serving the U.S. and international markets, with an alumni base of approximately 350,000.

Summary from 10-K filed 2025-08-07

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30
Revenue	1,788	1,585	1,451	1,382	899
Cost of educational services	771	699	648	660	458
Student services and administrative expense	672	633	586	566	292
Restructuring expense	3	2	19	26	7
Business integration expense	0	34	43	—	32
Gain on sale of assets	0	0	−13	0	0
Total operating cost and expense	1,447	1,368	1,283	1,305	789
Operating income	342	217	168	77	110
Interest expense	−52	−64	−63	−129	−41
Other income, net	9	11	7	1	7
Income from continuing operations before income taxes	299	164	112	−51	76
Provision for income taxes	−66	−26	−10	16	−12
Income from continuing operations	233	138	102	−36	63
Income (loss) from discontinued operations before income taxes	6	−762,000	−8	−986,000	9
Loss on disposal of discontinued operations before income taxes	0	0	−4	473	0
(Provision for) benefit from income taxes	−1	−174,000	4	−126	−3
Income (loss) from discontinued operations	4	−936,000	−8	347	6
Net income and comprehensive income	237	137	93	311	70
Continuing operations (In dollars per share)	6.27	3.49	2.27	−0.74	1.24
Discontinued operations (In dollars per share)	0.12	−0.02	−0.19	7.17	0.13
Total basic earnings per share (In dollar per share)	6.39	3.47	2.08	6.43	1.36
Continuing operations (In dollars per share)	6.07	3.42	2.23	−0.74	1.23
Discontinued operations (In dollars per share)	0.11	−0.02	−0.18	7.17	0.13
Total diluted earnings per share (In dollars per share)	6.18	3.39	2.05	6.43	1.36
Basic shares (In shares)	37	39	45	48	51
Diluted shares (In shares)	38	40	46	48	52

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2024 2024-03-31	FY 2023 2023-12-31	FY 2023 2023-09-30
Cash and cash equivalents	200	219	—	—	261
Restricted cash	2	2	—	—	4
Accounts and financing receivables, net	146	127	—	—	—
Prepaid expenses and other current assets	69	70	64	61	63
Total current assets	416	418	392	381	475
Property and equipment, net	256	249	240	235	247
Operating lease assets	191	177	—	—	—
Deferred income taxes	33	49	—	—	—
Intangible assets, net	765	777	—	—	—
Goodwill	961	961	—	—	—
Other assets, net	129	103	97	88	84
Assets held for sale	0	8	—	8	—
Total noncurrent assets	2,336	2,323	2,323	2,320	2,319
Total assets	2,752	2,741	—	—	—
Accounts payable	105	103	—	—	—
Accrued payroll and benefits	76	71	—	—	—
Accrued liabilities	77	97	—	—	—
Deferred revenue	214	185	—	—	—
Current operating lease liabilities	35	31	—	—	—
Total current liabilities	508	488	—	—	—
Long-term debt	553	649	—	—	—
Long-term operating lease liabilities	186	168	—	—	—
Deferred income taxes	32	30	—	—	—
Other liabilities	40	39	—	—	—
Total noncurrent liabilities	811	885	—	—	—
Total liabilities	1,319	1,372	—	—	—
Commitments and contingencies	—	—	—	—	—
Common stock, $0.01 par value per share, 200,000 shares authorized; 35,952 and 37,681 shares outstanding as of June 30, 2025 and June 30, 2024, respectively	839,000	832,000	—	—	—
Additional paid-in capital	664	612	—	—	—
Retained earnings	2,778	2,541	—	—	—
Accumulated other comprehensive loss	−2	−2	—	—	—
Treasury stock, at cost, 47,990 and 45,513 shares as of June 30, 2025 and June 30, 2024, respectively	−2,007	−1,782	—	—	—
Total shareholders' equity	1,434	1,369	—	—	—
Total liabilities and shareholders' equity	2,752	2,741	—	—	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30
Net income	237	137	93	311	—
Stock-based compensation	42	26	14	23	13
Amortization and impairments to operating lease assets	33	33	48	45	51
Depreciation	41	40	41	45	34
Amortization of acquired intangible assets	11	36	61	97	0
Amortization and write-off of debt discount and issuance costs	6	6	9	43	3
Provision for bad debts	63	53	33	27	—
Deferred income taxes	18	11	−5	−544,000	62,000
Loss on disposals and impairments of property and equipment	3	466,000	4	4	2
Gain on extinguishment of debt	0	0	−71,000	−2	0
(Gain) loss on investments	−1	−1	4	3	−3
Loss on assets held for sale	500,000	600,000	0	0	—
Accounts and financing receivables	−81	−76	−56	−41	15
Prepaid expenses and other current assets	6	−9	9	−3	−18
Cloud computing implementation assets	−33	−27	−14	0	—
Accounts payable	140,000	18	25	−16	6
Accrued payroll and benefits	5	19	−16	−12	13
Accrued liabilities	−16	27	241,000	−16	29
Deferred revenue	34	41	6	70	13
Operating lease liabilities	−25	−37	−59	−49	−49
Other assets and liabilities	−5	−10	1	−16	−14
Net cash provided by operating activities-continuing operations	334	288	195	164	169
Net cash provided by (used in) operating activities-discontinued operations	4	7	−3	−153	23
Net cash provided by operating activities	338	296	192	11	192
Capital expenditures	−50	−49	−26	−31	−40
Proceeds from sales of marketable securities	3	2	8	3	3
Purchases of marketable securities	−2	−689,000	−2	−4	−11
Proceeds from sale of assets	7	0	0	—	—
Proceeds from note receivable related to property sold	0	0	47	0	0
Net cash (used in) provided by investing activities-continuing operations	−42	−48	27	−1,509	−48
Payment for working capital adjustment for sale of business	0	0	−3	0	0
Net cash (used in) provided by investing activities	−42	−48	24	−552	−57
Proceeds from exercise of stock options	10	17	3	9	1
Employee taxes paid on withholding shares	−14	−8	−5	−3	−4
Proceeds from stock issued under Colleague Stock Purchase Plan	1	810,000	608,000	535,000	262,000
Repurchases of common stock for treasury	−213	−262	−123	−120	−100
Payment on equity forward contract	0	0	−13	−30	0
Proceeds from issuance of long-term debt	10	2	0	850	800
Repayments of long-term debt	−110	−52	−151	−1,080	−3
Net cash used in financing activities	−316	−302	−289	−424	676
Net decrease in cash, cash equivalents and restricted cash	−20	−54	−73	−966	813
Interest paid	47	58	53	107	14
Income taxes paid, net	33	31	12	94	26
Accrued capital expenditures	9	9	5	4	3
Accrued liability for repurchases of common stock	0	0	3	0	0
Accrued excise tax on share repurchases	2	3	1	0	0
Settlement of financing liability with assets	0	0	39	0	0

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Covista Inc.'s CIK number?

Covista Inc.'s SEC CIK number is 0000730464 (730464). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Covista Inc.'s SEC filings?

All of Covista Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Covista Inc. last report earnings?

Covista Inc. (CVSA) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000730464-26-000021). This is Covista Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is Covista Inc.'s most recent earnings 8-K?

Covista Inc.'s latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0000730464-26-000021. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Covista Inc.'s latest earnings 8-K →
Look up any company's CIK number →